Search - tctmd.com

Displaying 101 - 120 of 836

Sort: Relevancy | Date

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Conference News ACC 2023

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Michael O'Riordan

March 09, 2023

News Conference News ACC 2023

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Michael O'Riordan

March 06, 2023

Presentation ACC 2023

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Presenter: Roberto Diletti

March 05, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM

Yael L. Maxwell

February 15, 2023

News Daily News

Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL

Michael O'Riordan

February 15, 2023

News Daily News

Intravascular Imaging to Inform PCI Should Be Routine: ACC Interventional Council

Yael L. Maxwell

February 13, 2023

News Daily News

Prehospital Troponin Testing With EMS Input Could Save a Lot of Money

Michael O'Riordan

February 07, 2023

News Daily News

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Yael L. Maxwell

February 06, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

Michael O'Riordan

January 17, 2023

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

Michael O'Riordan

November 22, 2022

News Daily News

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Yael L. Maxwell

November 21, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI

Yael L. Maxwell

November 10, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

Advertisement

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM

Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL

Intravascular Imaging to Inform PCI Should Be Routine: ACC Interventional Council

Prehospital Troponin Testing With EMS Input Could Save a Lot of Money

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Many STEMI Patients Not Treated Within National Time Goals

Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content